BIOFRONTERA INC (BFRI) Stock Analyst Earnings Estimates
NASDAQ:BFRI - Nasdaq - US09077D2099 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 24.1M 27.85% | 28.67M 18.96% | 34.071M 18.84% | 40.098M 17.69% | 48.001M 19.71% | 60.995M 27.07% | 77.084M 26.38% | 99.041M 28.48% | 122.04M 23.22% | 147.8M 21.11% | 171.22M 15.85% | |
| EBITDA YoY % growth | -12.66M -59.85% | -17.19M -35.78% | -20.871M -21.41% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.2M -55.66% | -17.71M -34.17% | -21.375M -20.69% | -16.009M 25.10% | -6.993M 56.32% | 799.68K 111.44% | 10.155M 1,169.88% | 24.435M 140.62% | 39.41M 61.29% | 56.084M 42.31% | 71.507M 27.50% | |
| Operating Margin | -54.77% | -61.77% | -62.74% | -39.93% | -14.57% | 1.31% | 13.17% | 24.67% | 32.29% | 37.95% | 41.76% | |
| EPS YoY % growth | N/A | -9.60 83.16% | -19.27 -100.73% | -3.10 83.94% | -0.87 71.99% | 0.03 103.53% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 98.58% | -0.25 91.32% | -0.42 -746.60% | -0.33 66.17% | 0.13 600.00% |
| Revenue Q2Q % growth | 14.821M 39.87% | 11.73M 48.26% | 9.588M 22.31% | 10.557M 17.14% | 16.126M 8.81% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 200.43K 105.23% | -1.961M 64.13% | -3.338M 34.17% | -2.704M 45.49% | 1.009M 403.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.98 78.88% | -0.85 | -0.13 | -15.06% |
| Q2 2024 Q2Q % growth | -0.05 99.31% | -0.79 | 0.74 | 93.63% |
| Q1 2024 Q2Q % growth | -2.88 48.57% | -1.19 | -1.69 | -141.33% |
| Q4 2023 Q2Q % growth | -1.80 35.71% | -1.21 | -0.59 | -48.29% |
| Q3 2023 Q2Q % growth | -4.64 -110.91% | -3.86 | -0.78 | -20.19% |
| Q2 2023 Q2Q % growth | -7.23 -623.00% | -4.70 | -2.53 | -53.76% |
| Q1 2023 Q2Q % growth | -5.60 -55.56% | -3.98 | -1.62 | -40.77% |
| Q4 2022 Q2Q % growth | -2.80 -1,766.67% | -2.24 | -0.56 | -24.78% |
| Q3 2022 Q2Q % growth | -2.20 -10.00% | -5.92 | 3.72 | 62.81% |
| Q2 2022 Q2Q % growth | -1.00 | -6.94 | 5.94 | 85.58% |
| Q1 2022 Q2Q % growth | -3.60 | -3.26 | -0.34 | -10.29% |
| Q4 2021 Q2Q % growth | -0.15 | -0.18 | 0.03 | 18.30% |
| Q3 2021 Q2Q % growth | -2.00 | -0.59 | -1.41 | -238.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 9.012M 1.30% | 10.207M | -1.195M | -11.71% |
| Q2 2024 Q2Q % growth | 7.839M 34.05% | 8.371M | -532K | -6.36% |
| Q1 2024 Q2Q % growth | 7.912M -9.40% | 11.074M | -3.162M | -28.55% |
| Q4 2023 Q2Q % growth | 10.596M 4.50% | 11.752M | -1.156M | -9.84% |
| Q3 2023 Q2Q % growth | 8.896M 105.93% | 8.603M | 293K | 3.41% |
| Q2 2023 Q2Q % growth | 5.848M 31.12% | 6.304M | -456K | -7.23% |
| Q1 2023 Q2Q % growth | 8.733M -10.43% | 9.333M | -600K | -6.43% |
| Q4 2022 Q2Q % growth | 10.14M 10.58% | 10.565M | -425K | -4.02% |
| Q3 2022 Q2Q % growth | 4.32M -0.23% | 4.394M | -74K | -1.68% |
| Q2 2022 Q2Q % growth | 4.46M -23.89% | 4.629M | -169K | -3.65% |
| Q1 2022 Q2Q % growth | 9.75M 105.70% | 10.098M | -348K | -3.45% |
| Q4 2021 Q2Q % growth | 9.17M 7.00% | 9.422M | -252K | -2.67% |
| Q3 2021 Q2Q % growth | 4.33M 33.23% | 4.399M | -69K | -1.57% |
| Q2 2021 Q2Q % growth | 5.86M 144.17% | % | ||
| Q1 2021 Q2Q % growth | 4.74M 2.60% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -110.2% | 0% | 5.6% |
| Revenue | 0% | -9.3% | 0% | -1.19% |